In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Spectracef , Meiact, Cefditoren pivoxil Drug Master File in Korea (Spectracef , Meiact, Cefditoren pivoxil KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Spectracef , Meiact, Cefditoren pivoxil. The MFDS reviews the Spectracef , Meiact, Cefditoren pivoxil KDMF as part of the drug registration process and uses the information provided in the Spectracef , Meiact, Cefditoren pivoxil KDMF to evaluate the safety and efficacy of the drug.
After submitting a Spectracef , Meiact, Cefditoren pivoxil KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Spectracef , Meiact, Cefditoren pivoxil API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Spectracef , Meiact, Cefditoren pivoxil suppliers with KDMF on PharmaCompass.